Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

ConditionsBreast Cancer, NOS CNS Primary Tumor, NOS Cervical Cancer, NOS Colorectal Cancer, NOS Leukemia, NOS Lymphoma, NOS Miscellaneous Neoplasm, NOS Non-Rhabdomyosarcoma Soft Tissue Sarcoma, NOS Testicular Nonseminomatous Germ Cell Tumor, NOS Thyroid Cancer, NOS Melanoma Bone Cancer, NOS

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-39

SponsorEastern Cooperative Oncology Group

About this trial

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Questionnaires

Treatment groups

400 Participants

are divided into 2 treatment groups

Locations347

Select a site below to view it on the map.

Alaska

Arizona

Arkansas

California

Colorado

Delaware

Georgia

Illinois

Iowa

Kansas

Kentucky

Louisiana

Maryland

Massachusetts

Minnesota

Missouri

Nebraska

Nevada

New Jersey

New York

North Carolina

Ohio

Oklahoma

Pennsylvania

South Carolina

Tennessee

Texas

Virginia

Washington

Wisconsin

Wyoming

Sponsors and collaborators

Eastern Cooperative Oncology Group

Lead sponsor

Source ClinicalTrials.gov